News & Articles

First collaboration product includes medical imaging capabilities to enable more personalized treatment decisions in cancer care

The VENTANA ROS1 (SP384) rabbit monoclonal primary antibody is designed to effectively identify elevated ROS1 protein expression

We celebrate the clinical laboratory products that have made the most difference to your lab work or point-of-care testing and reveal our most popular clinical content of the year

3D InSight Human Liver Disease platform provides the most physiologically relevant testing environment for efficacy and safety

Drop by and see SelectScience on booth #724 at this year's AACC conference in Anaheim, California, from August 4-8

Explore the techniques and technologies that are shaping the latest advancements in cancer research

Avacta’s first Affimer clinical candidate is a potent PD-L1 antagonist under development for solid tumor indications as the basis of bispecific and combination therapies

Help us celebrate the best new clinical assays, kits, instruments and devices by casting your vote today

IMMray™ PanCan-d blood-based test for early detection of pancreatic cancer now set for Q3 2020 launch

Mission Bio announces the potential for more impactful, dynamic therapy development and application for those with acute myeloid leukemia (AML)

A mass spec scientist, from a world-renowned clinical pathology laboratory, shares the secrets to their success in this exclusive SelectScience interview

Project to focus on data-driven cell conversions to produce cell therapies with potential application in wound healing, and oncology immunotherapy

The drug works by targeting the protein responsible for the death of heart cells during an attack

Immunology-focused pharma company INmune Bio is set to start first-in-man clinical trials with a promising anti-TNF compound that could revolutionize the treatment of Alzheimer’s disease and related symptoms

Calcium flow tracked in heart muscle fibres in real time

Lonza and AllCells team up to offer an extensive range of hematopoietic primary cells to reach the global scientific community

New research suggests that metal-based chemotherapies eliminate inhibitory components of the immune system

New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission

Five color, high-performance immunohistochemistry multiplexing solution to advance biomarker studies

Olympus AI algorithm could improve clinical pathology classifications

From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer